PsoProtectMe
当前数据的概述
当前数据
我们致力于分享PsoProtectMe摘要数据。这些数据是初步的，包括有限数量的参与者，因此不应用于指导临床决策。
Click here to read our recently published scientific research paper detailing PsoProtect data. A summary of this research can be found on the Psoriasis Association website here.
We have recently published another scientific research paper detailing shielding behaviour, which can be found here. A summary of this research can also be found on the Psoriasis Association website here.
0
PsoProtectMe调查完成
来自PsoProtectMe的前3787名参与者的摘要数据。
每个国家/地区的参与者（≥10个参与者）：
| Country | Participants | Country | Participants |
|---|---|---|---|
| Argentina | 79 | Netherlands | 26 |
| Australia | 37 | Norway | 17 |
| Brazil | 30 | Panama | 11 |
| Canada | 52 | Peru | 16 |
| Chile | 216 | Philippines | 56 |
| Denmark | 51 | Poland | 65 |
| Greece | 11 | Portugal | 203 |
| Hong Kong | 18 | Singapore | 13 |
| India | 30 | Spain | 71 |
| Ireland | 57 | Sweden | 39 |
| Italy | 33 | United Kingdom | 2110 |
| Japan | 97 | United States | 276 |
| Malaysia | 10 | Other (<10) | 163 |
平均年龄：46岁（范围3-91）
平均BMI：26.8千克/平方米
银屑病的类型：3178寻常型银屑病，807 点滴型银屑病，212 脓疱型银屑病，76 红皮病
性别：
吸烟状况：
并存的银屑病关节炎：
银屑病的治疗类型：
大流行期间银屑病严重程度的变化：
您是否已被诊断出或认为自己患有新冠状病毒？
您有否因新冠状病毒去过急诊室？
您有否因新冠状病毒住院？
您的新冠状病毒感染病好了吗？